601607 On Other Exchanges
601607 is not on other exchanges.

shanghai pharmaceuticals-a (601607) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd., together with its subsidiaries, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People’s Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers a range of products, including chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, such as cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic, as well as anti-tumor and immunomodulatory, musculo-skeletal, respiratory, genito-urinary and sex hormone, blood and blood-forming organ, neurological, and other therapeutic areas. It provides its products in various dosage forms that include tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it operates a network of retail pharmacy stores, as well as engages in consulting service, assets management, investment holding operations, etc. Further, the company manufactures and trades medicines and medical equipment; and rents properties, as well as wholesales chemicals and active pharmaceutical ingredients. As of December 31, 2015, it had 1,769 chain retail pharmacies under its brand family, including 1,167 directly operated pharmacies. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

39,844 Employees
Last Reported Date: 08/25/16
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

President, Executive Director and Convener of...
Total Annual Compensation: CNY2.0M
Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Proposes Amendments to Articles of Association

Shanghai Pharmaceuticals Holding Co., Ltd. announced at its extraordinary general meeting to be held on October 20, 2016, proposed amendments to the Articles of Association of the company.

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2016

Shanghai Pharmaceuticals Holding Co., Ltd. announced unaudited consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported revenue of RMB 59,695,358,000 against RMB 50,950,076,000 a year ago. Operating profit was RMB 2,221,429,000 against RMB 1,976,284,000 a year ago. Profit before income tax was RMB 2,581,577,000 against RMB 2,124,660,000 a year ago. Profit attributable to owners of the company was RMB 1,732,458,000 or RMB 0.64 per basic and diluted share against RMB 1,534,018,000 or RNB 0.57 per basic and diluted share a year ago. Net cash generated from operating activities was RMB 460,961,000 against RMB 110,636,000 a year ago. Purchases of property, plant and equipment and investment properties were RMB 693,319,000 against RMB 669,805,000 a year ago.

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Board Changes

The Board of Shanghai Pharmaceuticals Holding Co., Ltd. received written resignation notice from Mr. Zhou Jie, the chairman of the Board, on 25 August 2016. Mr. Zhou Jie has tendered his resignation from the office of the chairman of the Board, executive director and a member of the Nomination Committee due to his work arrangement. Upon the resignation of Mr. Zhou Jie, he will no longer hold any positions in the company. The Board resolved to nominate Mr. Zhou Jun as a non-executive director candidate for the sixth session of the Board. Mr. Zhou Jun is an economist. Mr. Zhou has over 20 years of professional experience in securities, merger and acquisition, finance, real estate, project planning and corporate management. He has been the vice chairman and the chief executive officer since August 2016, and the executive director of Shanghai Industrial Holdings Limited since April 2009 respectively. He also served as the chairman of Shanghai Shengtai Investment and Management Limited since June 2014, and has been the independent non-executive director of Zhejiang Expressway Co., Ltd.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 601607.
View Industry Companies

Industry Analysis


Industry Average

Valuation 601607 Industry Range
Price/Earnings 17.1x
Price/Sales 0.5x
Price/Book 1.7x
Price/Cash Flow 12.2x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.